Institution: | 1Department of Speech-Language Pathology, Hennepin County Medical Center, Minneapolis, Minnesota, U.S.A. *Otolaryngology & Head and Neck Surgery P.A.; and Department of Communication Disorders, University of Minnesota, Minneapolis, Minnesota, U.S.A. ?Department of Otolaryngology, Hennepin County Medical Center; and University of Minnesota, Minneapolis, Minnesota, U.S.A. ?Department of Neurology, and Hennepin County Medical Center, Minneapolis, Minnesota, U.S.A. |
Abstract: | A patient initially diagnosed with adductor-type spasmodic dysphonia was referred for botulinum toxin (Botox) injections, but found on subsequent evaluation to have amyotrophic lateral sclerosis, and therefore Botox was not administered. This unique case underscores the need to delay botulinum toxin treatments in any patient with recent onset symptoms, and to obtain thorough motor speech and voice, otolaryngologic, and neurologic evaluation in all patients prior to consideration for injection. |